KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $1.2 million.

  • Dynavax Technologies' Capital Expenditures fell 809.81% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 11959.97%. This contributed to the annual value of $6.4 million for FY2024, which is 5477.58% up from last year.
  • As of Q3 2025, Dynavax Technologies' Capital Expenditures stood at $1.2 million, which was down 809.81% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Capital Expenditures ranged from a high of $3.9 million in Q1 2025 and a low of $347000.0 during Q3 2023
  • Moreover, its 5-year median value for Capital Expenditures was $1.5 million (2025), whereas its average is $1.8 million.
  • Per our database at Business Quant, Dynavax Technologies' Capital Expenditures skyrocketed by 126943.4% in 2021 and then tumbled by 7291.18% in 2023.
  • Over the past 5 years, Dynavax Technologies' Capital Expenditures (Quarter) stood at $3.0 million in 2021, then crashed by 47.73% to $1.6 million in 2022, then grew by 8.57% to $1.7 million in 2023, then soared by 101.86% to $3.5 million in 2024, then crashed by 64.43% to $1.2 million in 2025.
  • Its Capital Expenditures stands at $1.2 million for Q3 2025, versus $1.5 million for Q2 2025 and $3.9 million for Q1 2025.